Nuclear Medicine-Exam 3 UPDATED ACTUAL Questions and CORRECT
Answers
Identify two non-diffusible radiopharmaceuticals used to -99mTc DTPA
assess cerebral blood flow. -99mTc glucoheptonate
Identify two diffusible radiopharmaceuticals that perfuse -99mTc HMPAO
the brain by crossing the intact blood-brain barrier. -99mTc ECD
Identify conditions that may be identified by a brain per-
fusion study using a radiopharmaceutical that crosses the brain death, seizure origin, stroke, Alzheimer's disease
intact blood-brain barrier.
Identify conditions that may be identified by a brain perfu-
sion study using a radiopharmaceutical that demonstrates
brain death
blood flow to the brain without crossing the blood-brain
barrier.
Name the nuclear acquisition technique that best demon-
SPECT
strates all aspects of brain structure/function.
Identify the SPECT radiopharmaceutical used for Parkin-
I-123 Ioflupane (I-123 DaTscan)
son's disease.
Identify the radiopharmaceutical used for PET brain imag-
F-18 FDG
ing.
Name the two approved indications for performing PET -location of seizure foci
brain imaging. -evaluation of Alzheimer's
Name the radiopharmaceutical that is utilized for a cis-
111 Indium DTPA
ternogram study.
Name the method of dose administration for a cis-
intrathecal injection (spinal injection)
ternogram.
Identify the typical time frame necessary to complete a
static images taken at 6, 24, and 48 hours post-injection
cisternogram.
Define hydrocephalus. procedures.
Name the cardiac chamber imaged in nuclear cardiology
, hydrocephalus-excess fluid built up in brain
left ventricle
2/5
Answers
Identify two non-diffusible radiopharmaceuticals used to -99mTc DTPA
assess cerebral blood flow. -99mTc glucoheptonate
Identify two diffusible radiopharmaceuticals that perfuse -99mTc HMPAO
the brain by crossing the intact blood-brain barrier. -99mTc ECD
Identify conditions that may be identified by a brain per-
fusion study using a radiopharmaceutical that crosses the brain death, seizure origin, stroke, Alzheimer's disease
intact blood-brain barrier.
Identify conditions that may be identified by a brain perfu-
sion study using a radiopharmaceutical that demonstrates
brain death
blood flow to the brain without crossing the blood-brain
barrier.
Name the nuclear acquisition technique that best demon-
SPECT
strates all aspects of brain structure/function.
Identify the SPECT radiopharmaceutical used for Parkin-
I-123 Ioflupane (I-123 DaTscan)
son's disease.
Identify the radiopharmaceutical used for PET brain imag-
F-18 FDG
ing.
Name the two approved indications for performing PET -location of seizure foci
brain imaging. -evaluation of Alzheimer's
Name the radiopharmaceutical that is utilized for a cis-
111 Indium DTPA
ternogram study.
Name the method of dose administration for a cis-
intrathecal injection (spinal injection)
ternogram.
Identify the typical time frame necessary to complete a
static images taken at 6, 24, and 48 hours post-injection
cisternogram.
Define hydrocephalus. procedures.
Name the cardiac chamber imaged in nuclear cardiology
, hydrocephalus-excess fluid built up in brain
left ventricle
2/5
